Edw Pharma, Inc. (Formerly Itf Pharma, Inc.)

Edw Pharma, Inc. (Formerly Itf Pharma, Inc.) company information, Employees & Contact Information

EDW Pharma, Inc. (“EDW”) is a specialty pharmaceutical company primarily focused on neurology, women’s health, and urology. The company, which has field sales representation throughout the United States, specializes in marketing and commercializing pharmaceutical products manufactured by third parties. EDW is a privately held U.S. company with a long history of providing patients with safe and therapeutic solutions. With corporate headquarters based in Paoli, Pennsylvania, EDW’s consolidated operations include the EDW, Womens Choice Pharmaceuticals, and Edwards Pharmaceuticals divisions. Across these three divisions, the company offers a wide array of prescription products related to ALS (also known as Lou Gehrig’s disease), women’s health, urology, and over-the-counter cough and cold.

Company Details

Employees
38
Address
850 Cassatt Road,
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Berwyn, PA
Looking for a particular Edw Pharma, Inc. (Formerly Itf Pharma, Inc.) employee's phone or email?

Edw Pharma, Inc. (Formerly Itf Pharma, Inc.) Questions

News

ITF Pharma Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIGLUTIK® (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) with a Percutaneous Endoscopic Gastrostomy (PEG) Feeding Tube - PR Newswire

ITF Pharma Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIGLUTIK® (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) with a Percutaneous Endoscopic Gastrostomy (PEG) Feeding Tube PR Newswire

Tiglutik Now Available for the Treatment of Amyotrophic Lateral Sclerosis - Medical Professionals Reference

Tiglutik Now Available for the Treatment of Amyotrophic Lateral Sclerosis Medical Professionals Reference

ITF Pharma Receives Patient Impact Award for First and Only Easy-To-Swallow Thickened Liquid Treatment for Amyotrophic Lateral Sclerosis (ALS) - PR Newswire

ITF Pharma Receives Patient Impact Award for First and Only Easy-To-Swallow Thickened Liquid Treatment for Amyotrophic Lateral Sclerosis (ALS) PR Newswire

Top Edw Pharma, Inc. (Formerly Itf Pharma, Inc.) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant